CAS 1616703-93-5

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

CAS : 1616703-93-5

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

Degré de pureté : 95%

Masse moléculaire : 564.6g/mol

Ref: 54-PC110140

Ticagrelor EP Impurity C

CAS : 1616703-93-5

Formule : C₂₅H₃₀F₂N₆O₅S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 564.62

Ref: 4Z-T-817

Ticagrelor EP Impurity C

CAS : 1616703-93-5

Formule : C₂₅H₃₀F₂N₆O₅S

Masse moléculaire : 564.61

Ref: ST-EA-CP-T21003

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

CAS : 1616703-93-5

Degré de pureté : 95%

Masse moléculaire : 564.6099854

Ref: 10-F600691

Ticagrelor Acetate

Produit contrôlé

CAS : 1616703-93-5

Applications Ticagrelor Acetoxide is an acetoxy impurity of Ticagrelor (T437700). Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Formule : C₂₅H₃₀F₂N₆O₅S

Couleur et forme : White To Off-White

Masse moléculaire : 564.6

Ref: TR-D232265

Ticagrelor acetate

CAS : 1616703-93-5

Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor, preventing platelet aggregation. This chemical has been shown to reduce thrombus formation and improve survival rates after a heart attack. TICAGRELOR ACETATE: Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor,

Formule : C₂₅H₃₀F₂N₆O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 564.6 g/mol

Ref: 3D-RPC70393